BIIB vs VTI
Biogen Inc (BIIB) versus Vanguard Total Stock Market Index Fund ETF Shares (VTI) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Vanguard Total Stock Market Index Fund ETF Shares (VTI) common stock listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
VTI does not have a complete income-statement cache yet.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. VTI currently screens at market cap $0.
Not investment advice. Open the BIIB and VTI stock pages for the full models.
Not investment advice.